RxDoctor Payments Data

Jennifer Sweet, DPM

Podiatrist · Binghamton, NYNPI 1699941948

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (57.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Prodigy Surgical Distribution, Inc. at 56.7% of the total. Reporting peaked in 2021 at $9,538 and has fallen 87.1% since, to $1,231 in 2025. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,640in general payments, 2019–2025

Across 160 payments — averaging $147.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Prodigy Surgical Distribution, Inc.$13K
  • Treace Medical Concepts, Inc.$3K
  • Arthrex$3K
  • Stryker$2K
  • Baxter Healthcare$278
  • Organogenesis Inc.$262
  • plus $2K from 18 others

What the payments were for

  • Travel & lodging$5,26222%
  • Food & beverage$4,71020%
  • Education$13,66858%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,640 in reported general payments places this provider in the 95th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York

Medicare billing

Part B allowed, 2024
$35,544
Medicare patients
192
Services billed
484

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JubliaEfinaconazole13$25,201
Diclofenac Sodium14$440
Ciclopirox24$372
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip13$221
Doxycycline Monohydrate17$190
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen27$125

Paid to pharmacies, not to this prescriber.

Other podiatrist in Binghamton

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →